Spot gold trading just below Monday’s fresh record high
The chief executive of the pharmaceutical company Eli Lilly has said the UK is “probably the worst country in Europe” for drug prices, amid a row between the industry and government.
Dave Ricks said that the UK’s strict pricing regime, allowing it to pay less for drugs than other developed countries, means it would miss out on new drugs being rolled out if it did not raise prices and scrap a rebate scheme.
“Unless that changes I don’t think they will see many new medicines and I don’t think they will see much investment,” the boss of the Mounjaro weight loss drugmaker told the Financial Times. “That’s the UK’s choice, but we react to those choices.”
Our other main stories today:
